Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response

From MaRDI portal
Publication:2115998

DOI10.1016/J.JTBI.2021.111001zbMATH Open1483.92043arXiv2110.01545OpenAlexW3202858699WikidataQ113869617 ScholiaQ113869617MaRDI QIDQ2115998FDOQ2115998


Authors: Vasiliki Bitsouni, Vasilis Tsilidis Edit this on Wikidata


Publication date: 15 March 2022

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Abstract: tBregs are a newly discovered subcategory of B regulatory cells, which are generated by breast cancer, resulting in the increase of Tregs and therefore in the death of NK cells. In this study, we use a mathematical and computational approach to investigate the complex interactions between the aforementioned cells as well as CD8+ T cells, CD4+ T cells and B cells. Furthermore, we use data fitting to prove that the functional response regarding the lysis of breast cancer cells by NK cells has a ratio-dependent form. Additionally, we include in our model the concentration of rituximab - a monoclonal antibody that has been suggested as a potential breast cancer therapy - and test its effect, when the standard, as well as experimental dosages, are administered.


Full work available at URL: https://arxiv.org/abs/2110.01545




Recommendations




Cites Work


Cited In (7)

Uses Software





This page was built for publication: Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2115998)